Reversal Agent Use in Patients Treated With Direct Oral Anticoagulants or Vitamin K Antagonists

CompletedOBSERVATIONAL
Enrollment

272

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

June 30, 2018

Study Completion Date

July 9, 2019

Conditions
Severe BleedingUrgent Surgery
Trial Locations (1)

60389

Cardioangiology Center Bethanien (CCB), Frankfurt am Main

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Johannes Gutenberg University Mainz

OTHER

collaborator

University Hospital Greifswald

OTHER

collaborator

University Hospital Dresden

OTHER

collaborator

University Hospital, Aachen

OTHER

collaborator

Goethe University

OTHER

collaborator

University Hospital Schleswig-Holstein

OTHER

collaborator

Vivantes Netzwerk für Gesundheit GmbH

OTHER

collaborator

Ruhr University of Bochum

OTHER

collaborator

Technische Universität Dresden

OTHER

collaborator

Städtisches Klinikum Dresden-Friedrichstadt

UNKNOWN

lead

Cardioangiologisches Centrum Bethanien

OTHER

NCT01722786 - Reversal Agent Use in Patients Treated With Direct Oral Anticoagulants or Vitamin K Antagonists | Biotech Hunter | Biotech Hunter